Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Direxion S&P Biotech Bull 3X (LABU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Annual Dividend Yield N/A
  • Price/Earnings ttm 21.01
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.05 +19.98%
on 07/10/17
74.45 unch
on 07/24/17
+2.55 (+3.55%)
since 06/23/17
3-Month
41.40 +79.83%
on 05/31/17
74.45 unch
on 07/24/17
+27.46 (+58.44%)
since 04/24/17
52-Week
24.44 +204.62%
on 11/03/16
74.45 unch
on 07/24/17
+37.68 (+102.47%)
since 07/22/16

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X ETF and Direxion Daily MSCI India Bull 3

The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X...

NAIL : 46.60 (-0.94%)
KORU : 54.89 (+0.73%)
LABU : 74.45 (+3.81%)
CWEB : 43.29 (+2.68%)
INDL : 88.92 (+2.27%)
Best Leveraged ETFs of First Half of 2017

Inside the top five leveraged ETFs of the first half of 2017.

QQQ : 144.77 (+0.46%)
NAIL : 46.60 (-0.94%)
KORU : 54.89 (+0.73%)
LABU : 74.45 (+3.81%)
DIA : 215.09 (-0.20%)
SPY : 246.82 (-0.02%)
CWEB : 43.29 (+2.68%)
INDL : 88.92 (+2.27%)
Best Leveraged ETFs of First Half of 2017

Inside the top five leveraged ETFs of the first half of 2017.

QQQ : 144.77 (+0.46%)
NAIL : 46.60 (-0.94%)
KORU : 54.89 (+0.73%)
LABU : 74.45 (+3.81%)
DIA : 215.09 (-0.20%)
SPY : 246.82 (-0.02%)
CWEB : 43.29 (+2.68%)
INDL : 88.92 (+2.27%)
Stock Market Whiplash

Stock Market Whiplash

CAT : 108.18 (+1.49%)
LABU : 74.45 (+3.81%)
BREW : 18.30 (-0.81%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.55 (+1.34%)
BBC : 25.73 (+1.90%)
UBIO : 37.31 (+2.53%)
IBB : 327.34 (+0.76%)
BBH : 132.54 (+0.84%)
CLVS : 87.04 (+0.46%)
BIB : 59.46 (+1.64%)
LABU : 74.45 (+3.81%)
XBI : 81.75 (+1.21%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 41.55 (+1.34%)
BBC : 25.73 (+1.90%)
UBIO : 37.31 (+2.53%)
IBB : 327.34 (+0.76%)
BBH : 132.54 (+0.84%)
CLVS : 87.04 (+0.46%)
BIB : 59.46 (+1.64%)
LABU : 74.45 (+3.81%)
XBI : 81.75 (+1.21%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 25.73 (+1.90%)
CLDX : 2.39 (+1.27%)
CNCR : 24.39 (+1.50%)
IBB : 327.34 (+0.76%)
LABU : 74.45 (+3.81%)
KITE : 112.98 (+3.51%)
CGIX : 3.80 (-1.30%)
BBP : 41.55 (+1.34%)
SBIO : 29.64 (+1.61%)
UBIO : 37.31 (+2.53%)
INCY : 138.27 (+3.02%)
CLVS : 87.04 (+0.46%)
BIB : 59.46 (+1.64%)
XBI : 81.75 (+1.21%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 25.73 (+1.90%)
CLDX : 2.39 (+1.27%)
CNCR : 24.39 (+1.50%)
IBB : 327.34 (+0.76%)
LABU : 74.45 (+3.81%)
KITE : 112.98 (+3.51%)
CGIX : 3.80 (-1.30%)
BBP : 41.55 (+1.34%)
SBIO : 29.64 (+1.61%)
UBIO : 37.31 (+2.53%)
INCY : 138.27 (+3.02%)
CLVS : 87.04 (+0.46%)
BIB : 59.46 (+1.64%)
XBI : 81.75 (+1.21%)
Zacks Podcast Highlights: How Do Leveraged and Inverse ETFs Work?

Do you know how leveraged and inverse ETFs work? Find out in this edition of the Dutram Report, where we discuss that topic, and some of the hottest funds in the leveraged and inverse ETF world right now....

GUSH : 19.96 (-0.30%)
SPXL : 36.17 (-0.14%)
XOP : 31.62 (-0.09%)
LABU : 74.45 (+3.81%)
TMV : 19.32 (+0.99%)
CWEB : 43.29 (+2.68%)
XBI : 81.75 (+1.21%)
7 Best Leveraged ETFs So Far in 2017

Amid bouts of volatility, global stocks hit all-time highs on hopes of reflation trade and a slew of robust global data on export, employment and inflation.

BRZU : 33.45 (+0.81%)
JNUG : 16.99 (-5.72%)
EDC : 100.14 (+1.03%)
SHNY : 10.36 (-4.25%)
HAKK : 51.10 (-1.06%)
YINN : 26.03 (+0.97%)
LABU : 74.45 (+3.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Fund Summary

The Direxion Daily SP Biotech Bull 3x Shares seek daily investment results, before fees and expenses, of 300% or 300% of the inverse (or opposite) of the performance of the SP Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives.

See More

Support & Resistance

2nd Resistance Point 77.16
1st Resistance Point 75.80
Last Price 74.45
1st Support Level 71.74
2nd Support Level 69.04

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.